Jupiter Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Jupiter Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$54.9M	Buy	189,164 +30,423	+19%	+$8.25M	0.88%	30
2020 Q1	$37.8M	Buy	158,741 +693	+0.4%	+$159K	0.74%	37
2019 Q4	$34.6M	Buy	158,048 +54,127	+52%	+$11M	0.48%	64
2019 Q3	$17.6M	Sell	103,921 -439,480	-81%	-$77.7M	0.23%	123
2019 Q2	$99.6M	Sell	543,401 -363,443	-40%	-$63.5M	1.02%	26
2019 Q1	$167M	Buy	906,844 +166,393	+22%	+$30.7M	1.54%	15
2018 Q4	$123M	Sell	740,451 -677,397	-48%	-$117M	1.09%	31
2018 Q3	$273M	Sell	1,417,848 -282,358	-17%	-$50.3M	1.87%	9
2018 Q2	$289M	Buy	1,700,206 +307,536	+22%	+$47.7M	2.06%	2
2018 Q1	$227M	Sell	1,392,670 -35,457	-2%	-$5.79M	1.81%	13
2017 Q4	$214M	Buy	1,428,127 +226,097	+19%	+$33.5M	1.97%	7
2017 Q3	$183M	Buy	1,202,030 +6,575	+0.5%	+$990K	1.91%	7
2017 Q2	$154M	Buy	1,195,455 +1,114,939	+1,385%	+$134M	1.87%	3
2017 Q1	$8.8M	Buy	+80,516	New	+$7.09M	0.12%	123
2016 Q4	–	Sell	-49,672	Closed	-$4.33M	–	432
2016 Q3	$4.33M	Buy	+49,672	New	+$4.69M	0.08%	166

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jupiter Investment Management's VRTX Position: Q2 2020 in Review

Jupiter Investment Management increased its Vertex Pharmaceuticals (VRTX) stake by 19% in Q2 2020, buying an estimated $8.25M and bringing the position to 189,164 shares worth $54.9M. The position accounts for 0.88% of the portfolio, ranked #30.

Jupiter Investment Management first reported a position in VRTX in Q3 2016 and has held it in 15 quarters since. The position peaked at $289M in Q2 2018. 963 funds tracked by Wall St. Rank hold VRTX as of Q2 2020.

Jupiter Investment Management held 189,164 shares of Vertex Pharmaceuticals worth $54.9M as of Q2 2020.
Jupiter Investment Management bought 30,423 Vertex Pharmaceuticals shares in Q2 2020, an estimated $8.25M.
Vertex Pharmaceuticals made up 0.88% of Jupiter Investment Management's portfolio in Q2 2020, its #30 holding.
Jupiter Investment Management first reported a position in Vertex Pharmaceuticals in Q3 2016 and has held it in 15 quarters since.
Jupiter Investment Management's Vertex Pharmaceuticals position peaked at $289M in Q2 2018.
963 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.